CytoArt is not a conventional antibody supplier. We specialize in precision CAR-T detection and monitoring solutions spanning discovery, preclinical research, and translational applications. We also support in vivo CAR-T development through VHH binder discovery and engineering services for CAR design and targeted delivery applications.

CytoArt:

• Specialized in anti-idiotype antibodies for CAR-T monitoring applications
• Developed some of the earliest commercially available CAR-T detection anti-idiotype antibodies
• Offers detection reagents for most approved commercial CAR-T therapies in the U.S. and China
• Designs antibodies directly against CAR constructs (scFv or VHH), not general immune markers
• Supports CAR-T tracking and persistence studies in preclinical and translational research
• Provides custom anti-idiotype and VHH development for sponsor-specific CAR constructs

What types of collaborations does CytoArt support?

We collaborate with biotechnology companies, cell therapy developers, and academic research institutions in the following areas:

• Custom anti-idiotype antibody development
• CAR detection and monitoring assay development
• Co-development of novel CAR-T monitoring reagents
• VHH binder discovery and engineering for in vivo CAR applications
• Translational research and validation studies

To discuss a potential collaboration, please contact us at info@cytoart.com.

You can place an order through any of the following channels:

• Submit an inquiry through our website at www.cytoart.com
• Email your request or purchase order (PO) to info@cytoart.com
• Purchase through procurement platforms including VWR, Coupa, JAGGAER, and ZAGENO
• Contact your local distributor or CytoArt representative

We accept purchase orders from universities, hospitals, research institutes, and qualified commercial organizations.

To help us process your request efficiently, please provide:

• Catalog number(s)
• Product name(s)
• Quantity
• Shipping address
• Billing contact information

For quotation requests, please include any special shipping, documentation, or project requirements.

To evaluate a custom anti-idiotype antibody or CAR detection project, we typically request:

• CAR construct information (scFv, VHH, or target sequence)
• Intended application (e.g., flow cytometry, ELISA, IHC, qPCR validation, or other assays)
• Desired antibody format and labeling requirements
• Project objectives and timeline expectations

Project timelines vary depending on the complexity of the target and development scope. Following an initial technical review, CytoArt will provide a customized development plan, project milestones, and estimated delivery timeline.

• VHH binder discovery and engineering for targeted delivery applications
• Custom VHH generation against immune cell surface targets (e.g., CD4, CD8, CD3, and other customer-selected targets)
• Anti-idiotype antibody development for CAR detection and monitoring
• CAR expression, tracking, and persistence analysis in preclinical and translational research